Neil Stahl, SVP Research and Development S at REGENERON PHARMACEUTICALS INC (REGN), sold 55,438 shares at $276.71 ($15.1M) on 2013-05-13, disclosed to the SEC on 2013-05-14.
Open-market sale of $15.1M REGN by SVP Research and Development S. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $268.40 | 4,527 | $1.2M | 8.1% |
| 2 | $268.40 | 27,873 | $7.5M | 49.6% |
| 3 | $276.71 | 13,378 | $3.7M | 24.6% |
| 4 | $277.12 | 9,660 | $2.7M | 17.8% |
| Total | $271.92 avg | 55,438 | $15.1M | 100% |
| Filing → |
| REGN | SELL | 2023-08-23 | $19.6M | — | Filing → |
| REGN | SELL | 2022-08-08 | $28.4M | — | Filing → |
| REGN | SELL | 2021-05-18 | $18.2M | — | Filing → |